title: [Research progress of identifying predictive biomarkers for induction therapy in esophageal cancer].
abstract: Surgery is still the major treatment for esophageal cancer. It remains controversial, whether induction radiochemotherapy before resection can improve long-term survival for esophageal cancer patients. Researches have found that preoperative treatment only increases survival rates for patients who respond to induction therapy, but not for non-responders. Therefore, to identify the predictive biomarkers for induction therapy draw much attention. Although still far from satisfactory results, some have been obtained. Here, we summarize the potential biomarker candidates for reference.
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department One of Thoracic Surgery, Peking University School of Oncology, Peking University Cancer Hospital and Institute, Beijing 100142, China. chenkeneng@bjmu.edu.cn.
authors.forename: Yao
authors.initials: Y
authors.lastname: Lin
authors.forename: Keneng
authors.initials: K
authors.lastname: Chen
mesh_terms: D015415:Biomarkers; D059248:Chemoradiotherapy; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D006801:Humans; D020360:Neoadjuvant Therapy; D015996:Survival Rate
chemical_list: D015415:Biomarkers